Mary Ann Hodorowicz, RD, LDN, MBA, CDE, CEC
Mary Ann Hodorowicz is an RD and CDE and earned her MBA with a focus on marketing. She is also a Certified Endocrinology Coder and owns a private practice specializing in business clients in Palos Heights, Illinois.
She is a consultant, professional speaker, trainer and author for the health, food and pharmaceutical industries in nutrition, wellness, diabetes and Medicare and private insurance reimbursement.
Her clients include healthcare entities, professional membership associations, pharmacies, medical CEU education/training firms, government agencies, food and pharmaceutical companies, academia and employer groups.
She is on the faculty of several train-the-trainer programs, including the Johnson and Johnson Diabetes Institute, Pesi Healthcare, and a pharmacy program for training on DSMT accreditation by AADE, Present Diabetes e-Learning Systems, Balancing Life's Issues, and is on the speaker's bureau of Novartis/Nestle Nutrition, Inc..
Mary Ann has given over 300 professional presentations and webinars for several healthcare organizations and business entities. She has authored several resources, articles and tool kits for the Academy of Nutrition and Dietetics and AADE, has served on the editorial advisory board for AADE in Practice, and has continually served on president-elect committees of the Academy. Mary Ann is on the Board of Directors for AADE.
In her career, she has provided outpatient MNT and DSME, designed a hospital Outpatient Diabetes Center and recognized DSME program and worked as a Clinical Nutrition Manager, Assistant Director of a hospital Food and Nutrition Services Department and an ADA Dietetic Traineeship Director.
Italian Cauliflower Cinnamon Nutmeg Pumpkin Soup Slow Cook Beef and Barley Soup Caramel Apple Cider Almond Apricot Chutney Enchilada Dip Fudgy Brownies Lemon Parmesan Peas Baked Lamb and Vegetables Chicken Oreganato
If you listen closely, you may hear the sound of 25 million Americans with diabetes rejoicing today. In a revolutionary movement, the FDA has given 510(k) approval on Abbott's HbA1C test which is expected to help millions of Americans with Type 1 or 2 diabetes or those at risk. Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1C (HbA1C) test is a dramatic shift in diabetes diagnosis and monitoring. Instead of the HbA1C tests performed at a laboratory and constituted as blood work, the...